Cnb Bank Viking Therapeutics, Inc. Transaction History
Cnb Bank
- $195 Million
- Q1 2025
A detailed history of Cnb Bank transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Cnb Bank holds 5,330 shares of VKTX stock, worth $152,544. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,330
Previous 2,206
141.61%
Holding current value
$152,544
Previous $88,000
45.45%
% of portfolio
0.07%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding VKTX
# of Institutions
439Shares Held
64.7MCall Options Held
5.79MPut Options Held
3.72M-
Vanguard Group Inc Valley Forge, PA10.2MShares$291 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$172 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$141 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$74.2 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$61.7 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.19B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...